 |
61 Diseases |  |
24 Trials |
|
24 Trials |  |
800 News |  |
| «12...234567891011121314 |
- carbidopa/levodopa / Generic mfg.
Trial primary completion date: Antipsychotic Augmentation With L-Dopa (clinicaltrials.gov) - Sep 8, 2014
P2, N=24, Recruiting, Sponsor: Centre for Addiction and Mental Health
Trial primary completion date: Sep 2014 --> Sep 2015
- carbidopa/levodopa / Generic mfg., naproxen ER / Generic mfg., naproxen / Generic mfg.
Trial initiation date: Effect of L-dopa In Subacute Back Pain Population (clinicaltrials.gov) - Aug 21, 2014
P4, N=150, Not yet recruiting, Sponsor: Northwestern University
Trial primary completion date: Sep 2014 --> Sep 2015 Initiation date: May 2014 --> Oct 2014
- || carbidopa/levodopa / Generic mfg.
Clinical: Global REsponsE During iNFusIon of a gEl With LevoDopa/Carbidopa (clinicaltrials.gov) - Jul 18, 2014
P=N/A, N=150, Active, not recruiting, Sponsor: AbbVie (prior sponsor, Abbott)
Initiation date: May 2014 --> Oct 2014 Recruiting --> Active, not recruiting
- Accordion Pill carbidopa/levodopa CR (carbidopa/levodopa CR) / Jazz, Indaptus Therap
Trial suspension: Gastric Retentive Carbidopa/ Levodopa in Parkinson's Patients; a One Year, Open Label, Safety Extension Study (clinicaltrials.gov) - May 24, 2014
P2, N=36, Suspended, Sponsor: Intec Pharma Ltd.
Recruiting --> Active, not recruiting Not yet recruiting --> Suspended
- carbidopa/levodopa / Generic mfg., amphetamine / Generic mfg.
Trial primary completion date: Neurobiological Principles Applied to the Rehabilitation of Stroke Patients (clinicaltrials.gov) - May 12, 2014
P=N/A, N=26, Recruiting, Sponsor: Emory University
Not yet recruiting --> Suspended Trial primary completion date: May 2014 --> Dec 2014
- carbidopa/levodopa / Generic mfg., amphetamine / Generic mfg.
Trial completion date: Neurobiological Principles Applied to the Rehabilitation of Stroke Patients (clinicaltrials.gov) - May 12, 2014
P=N/A, N=26, Recruiting, Sponsor: Emory University
Trial primary completion date: May 2014 --> Dec 2014 Trial completion date: Jul 2014 --> Jul 2015
- | carbidopa/levodopa / Generic mfg.
Clinical: Global REsponsE During iNFusIon of a gEl With LevoDopa/Carbidopa (clinicaltrials.gov) - May 1, 2014
P=N/A, N=150, Recruiting, Sponsor: AbbVie (prior sponsor, Abbott)
Trial completion date: Jul 2014 --> Jul 2015 Trial completion date: Sep 2015 --> Feb 2016
- Ergonex (ergotamine/caffeine) / AC Farma
Trial primary completion date: Treatment of Orthostatic Hypotension in Autonomic Failure (clinicaltrials.gov) - May 1, 2014
P3, N=500, Recruiting, Sponsor: Vanderbilt University
Trial completion date: Sep 2015 --> Feb 2016 Trial primary completion date: May 2014 --> May 2015
- Ergonex (ergotamine/caffeine) / AC Farma
Trial completion date: Treatment of Orthostatic Hypotension in Autonomic Failure (clinicaltrials.gov) - May 1, 2014
P3, N=500, Recruiting, Sponsor: Vanderbilt University
Trial primary completion date: May 2014 --> May 2015 Trial completion date: May 2014 --> May 2016
- carbidopa/levodopa / Generic mfg., naproxen ER / Generic mfg., naproxen / Generic mfg.
New P2 trial: Efficacy of Co-administration of an NSAID With a Dopamine Agonist In Healthy Subjects (clinicaltrials.gov) - Apr 15, 2014
P2, N=40, Not yet recruiting, Sponsor: Northwestern University
- | carbidopa/levodopa / Generic mfg.
New P1 trial: LCD18K: Pharmacokinetic Study With Levodopa-carbidopa Fixed-dose Products in Healthy Subjects After Oral Administration (clinicaltrials.gov) - Apr 15, 2014
P1, N=12, Completed, Sponsor: Desitin Arzneimittel GmbH
- carbidopa/levodopa / Generic mfg., naproxen ER / Generic mfg., naproxen / Generic mfg.
Trial initiation date: Effect of L-dopa In Subacute Back Pain Population (clinicaltrials.gov) - Apr 14, 2014
P4, N=150, Not yet recruiting, Sponsor: Northwestern University
Trial completion date: May 2014 --> May 2016 Initiation date: Mar 2014 --> May 2014
- | carbidopa/levodopa / Generic mfg., levodopa/carbidopa orally disintegrating tablets / Generic mfg.
New P2 trial: Striatal Effective Connectivity to Predict Treatment Response in Cocaine Misuse (clinicaltrials.gov) - Mar 4, 2014
P2, N=90, Recruiting, Sponsor: Virginia Commonwealth University
- | cabergoline / Generic mfg., carbidopa/levodopa / Generic mfg.
Trial completion: Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease (clinicaltrials.gov) - Feb 22, 2014
P=N/A, N=30, Completed, Sponsor: Institute for Neurodegenerative Disorders
Initiation date: Mar 2014 --> May 2014 Recruiting --> Completed
- | carbidopa/levodopa / Generic mfg.
Enrollment closed: ATS17: Levodopa for the Treatment of Residual Amblyopia (clinicaltrials.gov) - Nov 18, 2013
P3, N=139, Active, not recruiting, Sponsor: Jaeb Center for Health Research
Recruiting --> Completed Recruiting --> Active, not recruiting
- | carbidopa/levodopa / Generic mfg.
Enrollment closed: A Trial of Levodopa in Angelman Syndrome (clinicaltrials.gov) - Nov 17, 2013
P2/3, N=100, Active, not recruiting, Sponsor: Wen-Hann Tan
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- | carbidopa/levodopa / Generic mfg., naproxen ER / Generic mfg., naproxen / Generic mfg.
New P4 trial: Effect of L-dopa In Subacute Back Pain Population (clinicaltrials.gov) - Sep 24, 2013
P4, N=150, Not yet recruiting, Sponsor: Northwestern University
- carbidopa/levodopa / Generic mfg.
Enrollment open: Study to Assess Safety, Tolerability and MTD of a Central Pattern Generator-activating Tritherapy (SPINALON) in Patients With Chronic Spinal Cord Injury (clinicaltrials.gov) - Jul 18, 2013
P1/2, N=51, Recruiting, Sponsor: Nordic Life Science Pipeline Inc.
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- ||| carbidopa/levodopa / Generic mfg.
Clinical: Global REsponsE During iNFusIon of a gEl With LevoDopa/Carbidopa (clinicaltrials.gov) - Jan 7, 2013
P=N/A, N=150, Recruiting, Sponsor: AbbVie (prior sponsor, Abbott)
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- | Inbrija (levodopa inhalation powder) / Acorda
Trial completion: Safety, Pharmacokinetics and Efficacy Study of CVT-301 Inpatients With Parkinson's Disease and "Off" Episodes (clinicaltrials.gov) - Dec 20, 2012
P2, N=25, Completed, Sponsor: Civitas Therapeutics
Not yet recruiting --> Recruiting Recruiting --> Completed
- | Accordion Pill carbidopa/levodopa CR (carbidopa/levodopa CR) / Jazz, Indaptus Therap
Trial initiation date: Gastric Retentive Carbidopa/ Levodopa in Parkinson's Patients; a One Year, Open Label, Safety Extension Study (clinicaltrials.gov) - Dec 5, 2012
P2, N=36, Not yet recruiting, Sponsor: Intec Pharma Ltd.
Recruiting --> Completed Initiation date: Sep 2012 --> Feb 2013
- carbidopa/levodopa / Generic mfg.
Trial withdrawal: Use of Zolpidem in Parkinson's Disease (clinicaltrials.gov) - Nov 29, 2012
P2, N=0, Withdrawn, Sponsor: Rush University Medical Center
Initiation date: Sep 2012 --> Feb 2013 Not yet recruiting --> Withdrawn
- carbidopa/levodopa / Generic mfg.
Enrollment change: Use of Zolpidem in Parkinson's Disease (clinicaltrials.gov) - Nov 29, 2012
P2, N=0, Withdrawn, Sponsor: Rush University Medical Center
Not yet recruiting --> Withdrawn N=40 --> 0
- methylphenidate tablet / Generic mfg., carbidopa/levodopa / Generic mfg.
Trial completion: Dopaminergic Modulation of Cognition and Psychomotor Function (clinicaltrials.gov) - Oct 23, 2012
P=N/A, N=20, Completed, Sponsor: Maastricht University Medical Center
N=40 --> 0 Recruiting --> Completed
- ||||| carbidopa/levodopa / Generic mfg.
New P4 trial: REIN-PD: Remission of ICD by Switching Dopamine Agonist to Levodopa/Carbidopa (clinicaltrials.gov) - Sep 9, 2012
P4, N=78, Not yet recruiting, Sponsor: Sandoz Korea
- carbidopa/levodopa / Generic mfg.
Enrollment open: Antipsychotic Augmentation With L-Dopa (clinicaltrials.gov) - Sep 5, 2012
P2, N=24, Recruiting, Sponsor: Centre for Addiction and Mental Health
Recruiting --> Completed Not yet recruiting --> Recruiting
- carbidopa/levodopa / Generic mfg., levodopa/carbidopa orally disintegrating tablets / Generic mfg.
New P2 trial: Vision Response to Dopamine Replacement (clinicaltrials.gov) - Aug 12, 2012
P2, N=50, Recruiting, Sponsor: University of Wisconsin, Madison
- | Accordion Pill carbidopa/levodopa CR (carbidopa/levodopa CR) / Jazz, Indaptus Therap
Enrollment change: Gastric Retentive Carbidopa/ Levodopa in Parkinson's Patients; a One Year, Open Label, Safety Extension Study (clinicaltrials.gov) - Jul 31, 2012
P2, N=36, Not yet recruiting, Sponsor: Intec Pharma Ltd.
Not yet recruiting --> Recruiting N=72 --> 36
- carbidopa/levodopa / Generic mfg.
Trial completion: PharmacoMRI of Parkinson Disease (clinicaltrials.gov) - Jul 24, 2012
P=N/A, N=18, Completed, Sponsor: Northwestern University
N=72 --> 36 Recruiting --> Completed
- carbidopa/levodopa / Generic mfg.
New P2 trial: Antipsychotic Augmentation With L-Dopa (clinicaltrials.gov) - Jul 8, 2012
P2, N=24, Recruiting, Sponsor: Centre for Addiction and Mental Health
- carbidopa/levodopa / Generic mfg.
Trial completion, Combination therapy: Augmenting Language Therapy for Aphasia: Levodopa (clinicaltrials.gov) - Jun 12, 2012
P2/3, N=36, Completed, Sponsor: Rehabilitation Institute of Chicago
Recruiting --> Completed Recruiting --> Completed
- | Inbrija (levodopa inhalation powder) / Acorda
New P2 trial: Safety, Pharmacokinetics and Efficacy Study of CVT-301 Inpatients With Parkinson's Disease and "Off" Episodes (clinicaltrials.gov) - Jun 10, 2012
P2, N=25, Completed, Sponsor: Civitas Therapeutics
- carbidopa/levodopa / Generic mfg.
Trial completion: Carbidopa/Levodopa Combined With Behavioral Therapy for the Treatment of Cocaine Dependence (clinicaltrials.gov) - Feb 29, 2012
P2, N=160, Completed, Sponsor: The University of Texas Health Science Center, Houston
Recruiting --> Completed Recruiting --> Completed
- | carbidopa/levodopa / Generic mfg.
New P1/2 trial: Study to Assess Safety, Tolerability and MTD of a Central Pattern Generator-activating Tritherapy (SPINALON) in Patients With Chronic Spinal Cord Injury (clinicaltrials.gov) - Nov 30, 2011
P1/2, N=51, Recruiting, Sponsor: Nordic Life Science Pipeline Inc.
- carbidopa/levodopa / Generic mfg.
New P2/3 trial, Combination therapy: Augmenting Language Therapy for Aphasia: Levodopa (clinicaltrials.gov) - Sep 1, 2011
P2/3, N=36, Completed, Sponsor: Rehabilitation Institute of Chicago